Aptose Biosciences - APTO Short Interest Ratio & Short Volume

Short interest is the volume of Aptose Biosciences shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 176,200 shares of APTO short. 0.21% of Aptose Biosciences' shares are currently sold short. Learn More on Aptose Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APTO shares currently have a short interest ratio of 1.0. Learn More on Aptose Biosciences's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptose Biosciences: Simplex Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.21% of Aptose Biosciences' floating shares are currently sold short.

Aptose Biosciences saw a increase in short interest in February. As of February 28th, there was short interest totaling 176,200 shares, an increase of 0.7% from the previous total of 175,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Aptose Biosciences currently has issued a total of 92,370,000 shares. Some of Aptose Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptose Biosciences currently has a public float of 85,650,000 shares.

0.21% of Aptose Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Aptose Biosciences: AVROBIO, Inc. (1.14%), Taysha Gene Therapies, Inc. (7.31%), Elevation Oncology, Inc. (0.27%), Eiger BioPharmaceuticals, Inc. (4.52%), TradeUP Acquisition Corp. (0.00%), Senti Biosciences, Inc. (1.92%), Curis, Inc. (2.75%), aTyr Pharma, Inc. (0.89%), Aziyo Biologics, Inc. (0.08%), and Aligos Therapeutics, Inc. (2.93%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Suncor Energy Inc. ($3.27 billion), Occidental Petroleum Co. ($2.77 billion), Coinbase Global, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.23 billion), Paramount Global ($1.92 billion), Etsy, Inc. ($1.75 billion), Voya Financial, Inc. ($1.74 billion), CarMax, Inc. ($1.62 billion), Old Dominion Freight Line, Inc. ($1.62 billion), and Royal Caribbean Cruises Ltd. ($1.39 billion). View all of the most shorted stocks.

Short selling APTO is an investing strategy that aims to generate trading profit from Aptose Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Aptose Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APTO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APTO, twice per month. The most recent reporting period available is February, 28 2023.